192 related articles for article (PubMed ID: 33606112)
21. Impairing the function of MLCK, myosin Va or myosin Vb disrupts Rhinovirus B14 replication.
Real-Hohn A; Provance DW; Gonçalves RB; Denani CB; de Oliveira AC; Salerno VP; Oliveira Gomes AM
Sci Rep; 2017 Dec; 7(1):17153. PubMed ID: 29215055
[TBL] [Abstract][Full Text] [Related]
22. DNA-AuNP networks on cell membranes as a protective barrier to inhibit viral attachment, entry and budding.
Li CM; Zheng LL; Yang XX; Wan XY; Wu WB; Zhen SJ; Li YF; Luo LF; Huang CZ
Biomaterials; 2016 Jan; 77():216-26. PubMed ID: 26606447
[TBL] [Abstract][Full Text] [Related]
23. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection.
Puddu P; Borghi P; Gessani S; Valenti P; Belardelli F; Seganti L
Int J Biochem Cell Biol; 1998 Sep; 30(9):1055-62. PubMed ID: 9785469
[TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin-3-gallate inhibits the early stages of Japanese encephalitis virus infection.
Wang CY; Hour MJ; Lai HC; Chen CH; Chang PJ; Huang SH; Lin CW
Virus Res; 2018 Jul; 253():140-146. PubMed ID: 29958923
[TBL] [Abstract][Full Text] [Related]
25. Lactoferrin inhibits human papillomavirus binding and uptake in vitro.
Drobni P; Näslund J; Evander M
Antiviral Res; 2004 Oct; 64(1):63-8. PubMed ID: 15451180
[TBL] [Abstract][Full Text] [Related]
26. Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.
Ammendolia MG; Agamennone M; Pietrantoni A; Lannutti F; Siciliano RA; De Giulio B; Amici C; Superti F
Pathog Glob Health; 2012 Mar; 106(1):12-9. PubMed ID: 22595270
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
28. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases.
Yuan M; Yan J; Xun J; Chen C; Zhang Y; Wang M; Chu W; Song Z; Hu Y; Zhang S; Zhang X
Virol J; 2018 Jan; 15(1):1. PubMed ID: 29298696
[TBL] [Abstract][Full Text] [Related]
29. Strategies for antiviral screening targeting early steps of virus infection.
Peng T
Virol Sin; 2010 Aug; 25(4):281-93. PubMed ID: 20960301
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
[TBL] [Abstract][Full Text] [Related]
31. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
32. Bovine lactoferrin increases the poly(I:C)-induced antiviral response in vitro.
Kobayashi-Sakamoto M; Maeda T; Kimura M; Yusa J; Ito H; Tani H; Kato Y; Hirose K
Biochem Cell Biol; 2022 Aug; 100(4):338-348. PubMed ID: 35830725
[TBL] [Abstract][Full Text] [Related]
33. Ficus religiosa L. bark extracts inhibit human rhinovirus and respiratory syncytial virus infection in vitro.
Cagno V; Civra A; Kumar R; Pradhan S; Donalisio M; Sinha BN; Ghosh M; Lembo D
J Ethnopharmacol; 2015 Dec; 176():252-7. PubMed ID: 26528588
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.
El-Fakharany EM; Sánchez L; Al-Mehdar HA; Redwan EM
Virol J; 2013 Jun; 10():199. PubMed ID: 23782993
[TBL] [Abstract][Full Text] [Related]
35. Lactoferrin inhibits early steps of human BK polyomavirus infection.
Longhi G; Pietropaolo V; Mischitelli M; Longhi C; Conte MP; Marchetti M; Tinari A; Valenti P; Degener AM; Seganti L; Superti F
Antiviral Res; 2006 Nov; 72(2):145-52. PubMed ID: 16774792
[TBL] [Abstract][Full Text] [Related]
36. Role of sialylated glycans on bovine lactoferrin against influenza virus.
Wang X; Yue L; Dang L; Yang J; Chen Z; Wang X; Shu J; Li Z
Glycoconj J; 2021 Dec; 38(6):689-696. PubMed ID: 34779975
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin.
Li S; Zhou H; Huang G; Liu N
Med Microbiol Immunol; 2009 Feb; 198(1):19-25. PubMed ID: 18810491
[TBL] [Abstract][Full Text] [Related]
38. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins.
Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM
Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141
[TBL] [Abstract][Full Text] [Related]
39. Bovine lactoferrin activity against Chikungunya and Zika viruses.
Carvalho CAM; Casseb SMM; Gonçalves RB; Silva EVP; Gomes AMO; Vasconcelos PFC
J Gen Virol; 2017 Jul; 98(7):1749-1754. PubMed ID: 28699858
[TBL] [Abstract][Full Text] [Related]
40. [Study of inhibition effect of zinc-, iron- and manganese-saturated bovine lactoferrin on hepatitis B virus DNA in vitro].
Zhou H; Li S; Huang G; Liu N
Wei Sheng Yan Jiu; 2008 Sep; 37(5):586-9. PubMed ID: 19069661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
